XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.830
+0.060 (3.39%)
Nov 21, 2024, 3:54 PM EST - Market closed
XTL Biopharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | - | -1.78 | -1.35 | 0.44 | -2.95 | -0.76 | |
| Depreciation & Amortization | - | - | 0 | 0 | 0 | - | |
| Loss (Gain) From Sale of Investments | - | 1.02 | 1.53 | -0.75 | -0.14 | 0.57 | |
| Stock-Based Compensation | - | 0 | 0.01 | 0.04 | 0.05 | 0.01 | |
| Other Operating Activities | - | -0.01 | -1.08 | -0.72 | 2.15 | -0.67 | |
| Change in Accounts Payable | - | 0.02 | -0.04 | -0.02 | 0.02 | -0.02 | |
| Change in Other Net Operating Assets | - | 0.05 | 0.03 | -0.03 | 0.02 | -0.03 | |
| Operating Cash Flow | - | -0.71 | -0.9 | -1.05 | -0.85 | -0.91 | |
| Capital Expenditures | - | - | - | - | -0 | -0 | |
| Investment in Securities | - | - | - | - | - | 2.02 | |
| Other Investing Activities | - | 0.04 | 0.04 | 0.01 | 0.03 | 0.09 | |
| Investing Cash Flow | - | 0.04 | 0.04 | 0.01 | 0.03 | 2.11 | |
| Issuance of Common Stock | - | - | - | 0.39 | - | - | |
| Financing Cash Flow | - | - | - | 0.39 | - | - | |
| Foreign Exchange Rate Adjustments | - | -0.03 | -0.01 | -0.01 | -0.01 | -0 | |
| Net Cash Flow | - | -0.69 | -0.88 | -0.66 | -0.82 | 1.2 | |
| Free Cash Flow | - | -0.71 | -0.9 | -1.05 | -0.85 | -0.91 | |
| Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| Levered Free Cash Flow | - | -0.41 | -0.55 | -0.66 | -0.5 | -0.57 | |
| Unlevered Free Cash Flow | - | -0.41 | -0.55 | -0.66 | -0.5 | -0.57 | |
| Change in Net Working Capital | 0.16 | -0.06 | 0.02 | 0.05 | -0.05 | 0.05 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.